Client News

Amesite Inc. (Nasdaq: AMST) Presenting at The Microcap Conference on January 29

CEO to Provide Update on Company’s NurseMagic™ App DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) — Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference is taking place […]

Samantha A. Ciulla Joins Inspire Veterinary Partners (Nasdaq:IVP) as Director of Business Development

Ciulla has over a decade of leadership experience in operations, acquisition integration and business development within the veterinary sector VIRGINIA BEACH, VA / ACCESS Newswire / January 29, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced the appointment of Samatha A. […]

SMX’s (NASDAQ:SMX) Molecular-Level Cybersecurity Solutions Are Critical Upgrades to a $300 Billion Market Needing Supply Chain and Operational Resiliency

MIAMI, FLORIDA / ACCESS Newswire / January 29, 2025 / Cyberattacks are one of the most pressing threats to global stability, disrupting not just industries but entire economies. From the Stuxnet malware to the infamous Colonial Pipeline attack, cyber incidents have targeted critical infrastructure and operational technologies (OT), showcasing their devastating physical and financial consequences. These breaches highlight […]

NanoViricides (NYSE American:NNVC) to Present at the MicroCap Conference on Wednesday, January 29, 2025

SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ. Event Information: Event NanoViricides Presentation at the MicroCap Conference, […]

Rezolve Ai (NASDAQ: RZLV) Defies the AI Cost Spiral with brainpowa LLM – Smarter, Leaner, and Built for Retail Success – Pioneering DeepSeek’s Approach Years Ahead

Delivering high-performance AI without the ‘black hole of capital’ required by traditional LLMs, showing that smarter, leaner models can drive better Ai outcomes NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in AI-driven retail innovation, proudly announces that its groundbreaking large language model, brainpowa, has been engineered from the very […]

NanoViricides (NYSE American:NNVC) Engages CRO for Phase II Clinical Trial

SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline. “NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.